azoxymethane has been researched along with efatutazone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fields, AP; Fujiwara, K; Kurakata, S; Murray, NR; Necela, BM; Su, W; Thompson, EA | 1 |
1 other study(ies) available for azoxymethane and efatutazone
Article | Year |
---|---|
The high affinity peroxisome proliferator-activated receptor-gamma agonist RS5444 inhibits both initiation and progression of colon tumors in azoxymethane-treated mice.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinogens; Cell Transformation, Neoplastic; Colonic Neoplasms; Disease Progression; Immunohistochemistry; Mice; Mice, Inbred C57BL; PPAR gamma; Thiazolidinediones | 2008 |